A detailed history of Jones Financial Companies Lllp transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 1,618 shares of NTLA stock, worth $19,707. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,618
Previous 729 121.95%
Holding current value
$19,707
Previous $16,000 106.25%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$19.72 - $27.36 $17,531 - $24,323
889 Added 121.95%
1,618 $33,000
Q2 2024

Aug 14, 2024

BUY
$20.02 - $27.22 $13,893 - $18,890
694 Added 1982.86%
729 $16,000
Q1 2024

May 14, 2024

BUY
$23.82 - $32.8 $833 - $1,148
35 New
35 $0

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $926M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.